Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cross Infection | 33 | 2024 | 1422 | 4.380 |
Why?
|
Hospitals, Community | 12 | 2024 | 365 | 2.300 |
Why?
|
Anti-Bacterial Agents | 30 | 2024 | 7407 | 1.930 |
Why?
|
Mupirocin | 9 | 2023 | 55 | 1.810 |
Why?
|
Chlorhexidine | 10 | 2023 | 160 | 1.640 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 18 | 2023 | 696 | 1.620 |
Why?
|
Sepsis | 14 | 2024 | 2585 | 1.570 |
Why?
|
Infection Control | 19 | 2024 | 983 | 1.320 |
Why?
|
Catheter-Related Infections | 4 | 2023 | 273 | 1.290 |
Why?
|
Anti-Infective Agents | 11 | 2023 | 983 | 1.260 |
Why?
|
Staphylococcal Infections | 17 | 2023 | 1401 | 1.170 |
Why?
|
Anti-Infective Agents, Local | 7 | 2023 | 247 | 1.050 |
Why?
|
Pneumonia, Ventilator-Associated | 9 | 2022 | 279 | 1.000 |
Why?
|
Baths | 5 | 2023 | 53 | 1.000 |
Why?
|
Bacteremia | 7 | 2022 | 978 | 0.930 |
Why?
|
Urinary Tract Infections | 5 | 2024 | 801 | 0.930 |
Why?
|
Intensive Care Units | 15 | 2023 | 3744 | 0.930 |
Why?
|
Carrier State | 8 | 2019 | 522 | 0.870 |
Why?
|
Drug Resistance, Microbial | 4 | 2019 | 826 | 0.820 |
Why?
|
Drug Resistance, Bacterial | 8 | 2020 | 1048 | 0.750 |
Why?
|
Bacterial Infections | 9 | 2019 | 1390 | 0.660 |
Why?
|
Carbapenems | 2 | 2018 | 123 | 0.640 |
Why?
|
Pharmacists | 5 | 2020 | 259 | 0.610 |
Why?
|
Nasal Mucosa | 2 | 2019 | 413 | 0.540 |
Why?
|
Drug Utilization | 3 | 2018 | 1188 | 0.520 |
Why?
|
Mandatory Reporting | 1 | 2017 | 123 | 0.510 |
Why?
|
Surgical Wound Infection | 6 | 2023 | 1530 | 0.470 |
Why?
|
Public Health | 5 | 2024 | 2672 | 0.450 |
Why?
|
Immunization Programs | 5 | 2013 | 267 | 0.440 |
Why?
|
Fungi | 1 | 2016 | 337 | 0.430 |
Why?
|
Disinfectants | 1 | 2014 | 129 | 0.430 |
Why?
|
Shock, Septic | 4 | 2024 | 769 | 0.430 |
Why?
|
Proton Pump Inhibitors | 1 | 2018 | 534 | 0.420 |
Why?
|
Drug Utilization Review | 4 | 2016 | 248 | 0.420 |
Why?
|
Cooperative Behavior | 5 | 2018 | 1506 | 0.410 |
Why?
|
Hospitals | 12 | 2023 | 3881 | 0.410 |
Why?
|
Monitoring, Physiologic | 1 | 2020 | 1780 | 0.400 |
Why?
|
Clostridium Infections | 1 | 2018 | 557 | 0.370 |
Why?
|
Disinfection | 5 | 2019 | 207 | 0.370 |
Why?
|
Infectious Disease Transmission, Professional-to-Patient | 1 | 2011 | 33 | 0.370 |
Why?
|
Disease Transmission, Infectious | 3 | 2019 | 561 | 0.360 |
Why?
|
Influenza, Human | 7 | 2013 | 1521 | 0.360 |
Why?
|
Societies | 1 | 2010 | 107 | 0.340 |
Why?
|
Drug Resistance, Multiple, Bacterial | 5 | 2024 | 585 | 0.340 |
Why?
|
Pharmacy Service, Hospital | 1 | 2009 | 134 | 0.300 |
Why?
|
Population Surveillance | 5 | 2020 | 2598 | 0.300 |
Why?
|
United States | 44 | 2024 | 72341 | 0.290 |
Why?
|
Bacteria | 2 | 2016 | 2190 | 0.290 |
Why?
|
Health Personnel | 5 | 2012 | 3337 | 0.280 |
Why?
|
Digestive System Surgical Procedures | 2 | 2023 | 571 | 0.270 |
Why?
|
Water Microbiology | 2 | 2024 | 113 | 0.270 |
Why?
|
Humans | 116 | 2024 | 761222 | 0.270 |
Why?
|
Communicable Diseases | 4 | 2023 | 873 | 0.260 |
Why?
|
Vaccination | 4 | 2011 | 3369 | 0.260 |
Why?
|
Community-Acquired Infections | 2 | 2017 | 469 | 0.260 |
Why?
|
Administration, Intranasal | 5 | 2023 | 476 | 0.260 |
Why?
|
Respiration, Artificial | 6 | 2013 | 2631 | 0.260 |
Why?
|
Texas | 3 | 2024 | 403 | 0.250 |
Why?
|
Drug and Narcotic Control | 2 | 2016 | 144 | 0.240 |
Why?
|
Administration, Topical | 2 | 2016 | 703 | 0.230 |
Why?
|
Iodophors | 1 | 2023 | 7 | 0.230 |
Why?
|
Influenza Vaccines | 4 | 2012 | 767 | 0.210 |
Why?
|
Quality Indicators, Health Care | 4 | 2021 | 1789 | 0.210 |
Why?
|
Candidiasis, Invasive | 1 | 2022 | 23 | 0.210 |
Why?
|
Ventilator-Induced Lung Injury | 2 | 2013 | 120 | 0.200 |
Why?
|
Medical Order Entry Systems | 2 | 2024 | 521 | 0.200 |
Why?
|
Practice Guidelines as Topic | 6 | 2019 | 7400 | 0.200 |
Why?
|
Mandatory Programs | 3 | 2011 | 86 | 0.190 |
Why?
|
Research Design | 5 | 2019 | 6180 | 0.180 |
Why?
|
Infection Control Practitioners | 2 | 2018 | 12 | 0.180 |
Why?
|
Pneumonia | 7 | 2024 | 2142 | 0.180 |
Why?
|
Antibiotic Prophylaxis | 2 | 2015 | 637 | 0.170 |
Why?
|
Streptococcus agalactiae | 2 | 1992 | 337 | 0.170 |
Why?
|
Delivery of Health Care | 8 | 2023 | 5333 | 0.170 |
Why?
|
Influenza A virus | 2 | 2013 | 458 | 0.160 |
Why?
|
Infectious Disease Medicine | 3 | 2016 | 49 | 0.160 |
Why?
|
Cellulitis | 3 | 1990 | 208 | 0.150 |
Why?
|
Staphylococcus aureus | 6 | 2023 | 1450 | 0.150 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2020 | 237 | 0.150 |
Why?
|
Nasal Cavity | 3 | 2014 | 304 | 0.150 |
Why?
|
Streptococcal Infections | 3 | 1992 | 617 | 0.150 |
Why?
|
Candidiasis | 2 | 2022 | 365 | 0.150 |
Why?
|
Personnel, Hospital | 2 | 2013 | 285 | 0.140 |
Why?
|
Disease Outbreaks | 2 | 2024 | 1747 | 0.140 |
Why?
|
Medicare | 4 | 2024 | 6774 | 0.140 |
Why?
|
Calcitonin | 1 | 2018 | 329 | 0.140 |
Why?
|
Epidemiology | 3 | 2016 | 280 | 0.140 |
Why?
|
Multiple Organ Failure | 1 | 2019 | 386 | 0.130 |
Why?
|
Electronic Health Records | 3 | 2019 | 4822 | 0.130 |
Why?
|
Inservice Training | 1 | 2018 | 375 | 0.130 |
Why?
|
Nose | 2 | 2016 | 521 | 0.120 |
Why?
|
Hospitalization | 5 | 2024 | 10707 | 0.120 |
Why?
|
Tracheoesophageal Fistula | 1 | 1996 | 130 | 0.120 |
Why?
|
Algorithms | 5 | 2013 | 14025 | 0.110 |
Why?
|
Ventilators, Mechanical | 2 | 2013 | 288 | 0.110 |
Why?
|
Emergency Service, Hospital | 3 | 2023 | 7865 | 0.110 |
Why?
|
Evidence-Based Medicine | 2 | 2019 | 3691 | 0.110 |
Why?
|
Pseudomonas Infections | 3 | 2015 | 621 | 0.110 |
Why?
|
Pandemics | 5 | 2023 | 8663 | 0.100 |
Why?
|
Influenza B virus | 1 | 2012 | 50 | 0.100 |
Why?
|
Hospitals, Urban | 1 | 2014 | 500 | 0.100 |
Why?
|
Wound Infection | 3 | 1992 | 244 | 0.100 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 1996 | 662 | 0.100 |
Why?
|
Aged | 25 | 2024 | 169292 | 0.100 |
Why?
|
Mycobacterium Infections | 2 | 2003 | 122 | 0.100 |
Why?
|
Retrospective Studies | 12 | 2023 | 80675 | 0.100 |
Why?
|
Cerebrospinal Fluid Rhinorrhea | 1 | 1992 | 86 | 0.100 |
Why?
|
Health Services Research | 2 | 2019 | 1807 | 0.100 |
Why?
|
Male | 36 | 2024 | 360703 | 0.100 |
Why?
|
Female | 29 | 2024 | 392552 | 0.100 |
Why?
|
Professional Role | 2 | 2018 | 313 | 0.100 |
Why?
|
Health Care Surveys | 3 | 2014 | 2425 | 0.100 |
Why?
|
Escherichia coli Infections | 1 | 2015 | 518 | 0.100 |
Why?
|
Cytomegalovirus | 1 | 1996 | 750 | 0.090 |
Why?
|
Osteomyelitis | 2 | 1990 | 407 | 0.090 |
Why?
|
Middle Aged | 30 | 2024 | 220858 | 0.090 |
Why?
|
Biomedical Research | 2 | 2017 | 3434 | 0.090 |
Why?
|
Drug Therapy, Combination | 2 | 2018 | 6304 | 0.090 |
Why?
|
Specialization | 2 | 2018 | 778 | 0.090 |
Why?
|
Pasteurella Infections | 1 | 1989 | 8 | 0.090 |
Why?
|
Meningitis, Bacterial | 1 | 1992 | 222 | 0.090 |
Why?
|
Adult | 32 | 2024 | 221120 | 0.090 |
Why?
|
Health Planning Guidelines | 1 | 2010 | 151 | 0.090 |
Why?
|
Vibrio Infections | 1 | 1990 | 33 | 0.090 |
Why?
|
Gastrointestinal Tract | 1 | 2016 | 834 | 0.080 |
Why?
|
Odds Ratio | 2 | 2021 | 9652 | 0.080 |
Why?
|
Cytomegalovirus Infections | 1 | 1996 | 828 | 0.080 |
Why?
|
Fluoroquinolones | 2 | 2015 | 307 | 0.080 |
Why?
|
Patient Discharge | 1 | 2022 | 3441 | 0.080 |
Why?
|
beta-Lactamases | 2 | 2009 | 304 | 0.080 |
Why?
|
Information Dissemination | 1 | 2017 | 1129 | 0.080 |
Why?
|
Cost Savings | 1 | 2014 | 911 | 0.080 |
Why?
|
Bursitis | 1 | 1989 | 80 | 0.080 |
Why?
|
Leadership | 1 | 2018 | 1385 | 0.080 |
Why?
|
Comparative Effectiveness Research | 2 | 2013 | 708 | 0.080 |
Why?
|
Mycoses | 1 | 2012 | 386 | 0.080 |
Why?
|
Tricuspid Valve | 1 | 1991 | 410 | 0.080 |
Why?
|
Drug Resistance, Multiple | 1 | 2009 | 255 | 0.080 |
Why?
|
Enterobacteriaceae Infections | 1 | 1990 | 187 | 0.070 |
Why?
|
Communicable Disease Control | 3 | 2023 | 846 | 0.070 |
Why?
|
Medical Informatics | 1 | 2014 | 733 | 0.070 |
Why?
|
Endocarditis, Bacterial | 1 | 1991 | 436 | 0.070 |
Why?
|
Seasons | 1 | 2013 | 1518 | 0.070 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2017 | 1186 | 0.070 |
Why?
|
Vancomycin | 3 | 2015 | 503 | 0.070 |
Why?
|
Endophthalmitis | 1 | 1989 | 260 | 0.070 |
Why?
|
Hospital Mortality | 4 | 2023 | 5295 | 0.070 |
Why?
|
Program Development | 1 | 2013 | 1294 | 0.070 |
Why?
|
Physicians | 2 | 2018 | 4584 | 0.070 |
Why?
|
Kidney Failure, Chronic | 1 | 2019 | 2478 | 0.070 |
Why?
|
Urban Population | 1 | 2014 | 2036 | 0.070 |
Why?
|
Safety | 1 | 2011 | 1151 | 0.070 |
Why?
|
Abscess | 1 | 1990 | 605 | 0.070 |
Why?
|
Research | 1 | 2014 | 1976 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 10756 | 0.070 |
Why?
|
Software | 1 | 2020 | 4431 | 0.070 |
Why?
|
Virus Diseases | 1 | 2012 | 716 | 0.060 |
Why?
|
Ofloxacin | 1 | 2005 | 66 | 0.060 |
Why?
|
Abortion, Induced | 1 | 1991 | 462 | 0.060 |
Why?
|
Health Resources | 1 | 2011 | 934 | 0.060 |
Why?
|
Aged, 80 and over | 9 | 2024 | 58952 | 0.060 |
Why?
|
Treatment Refusal | 1 | 2008 | 430 | 0.060 |
Why?
|
Mycobacterium tuberculosis | 1 | 1996 | 1912 | 0.060 |
Why?
|
Diagnosis, Differential | 3 | 2018 | 12976 | 0.060 |
Why?
|
Tuberculosis | 2 | 1996 | 2017 | 0.060 |
Why?
|
Prescription Drugs | 1 | 2012 | 631 | 0.060 |
Why?
|
Ceftriaxone | 1 | 2005 | 175 | 0.060 |
Why?
|
Opioid-Related Disorders | 1 | 2019 | 2164 | 0.060 |
Why?
|
Congresses as Topic | 1 | 2008 | 803 | 0.060 |
Why?
|
Ciprofloxacin | 1 | 2005 | 312 | 0.050 |
Why?
|
Health Policy | 3 | 2013 | 2679 | 0.050 |
Why?
|
Clinical Trials as Topic | 2 | 2017 | 8002 | 0.050 |
Why?
|
Emergency Medical Services | 1 | 2014 | 1920 | 0.050 |
Why?
|
National Institutes of Health (U.S.) | 2 | 2017 | 793 | 0.050 |
Why?
|
Echinocandins | 1 | 2022 | 53 | 0.050 |
Why?
|
Community Health Centers | 1 | 2006 | 461 | 0.050 |
Why?
|
Mycobacterium bovis | 1 | 2003 | 146 | 0.050 |
Why?
|
Skin | 1 | 2016 | 4473 | 0.050 |
Why?
|
Quality Assurance, Health Care | 2 | 2009 | 2164 | 0.050 |
Why?
|
Tampons, Surgical | 1 | 1981 | 10 | 0.050 |
Why?
|
Pneumonia, Bacterial | 1 | 2024 | 316 | 0.050 |
Why?
|
Oils, Volatile | 1 | 2021 | 14 | 0.050 |
Why?
|
Water Supply | 1 | 2002 | 204 | 0.050 |
Why?
|
Carrageenan | 1 | 2021 | 71 | 0.050 |
Why?
|
Nasal Sprays | 1 | 2021 | 24 | 0.050 |
Why?
|
Mycobacterium | 1 | 2002 | 251 | 0.050 |
Why?
|
Terpenes | 1 | 2021 | 96 | 0.050 |
Why?
|
Povidone-Iodine | 1 | 2021 | 55 | 0.050 |
Why?
|
Salicylates | 1 | 2021 | 127 | 0.040 |
Why?
|
Hypoglycemia | 2 | 2005 | 883 | 0.040 |
Why?
|
Young Adult | 5 | 2019 | 59222 | 0.040 |
Why?
|
BCG Vaccine | 1 | 2003 | 369 | 0.040 |
Why?
|
Cohort Studies | 3 | 2021 | 41496 | 0.040 |
Why?
|
Respiratory Tract Infections | 2 | 2019 | 1009 | 0.040 |
Why?
|
Program Evaluation | 2 | 2019 | 2489 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2019 | 6919 | 0.040 |
Why?
|
Reimbursement, Incentive | 1 | 2024 | 542 | 0.040 |
Why?
|
Infant, Newborn | 4 | 2022 | 26200 | 0.040 |
Why?
|
Hygiene | 1 | 2019 | 94 | 0.040 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2024 | 619 | 0.040 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2020 | 219 | 0.040 |
Why?
|
Antifungal Agents | 1 | 2022 | 752 | 0.040 |
Why?
|
Hydrogen Peroxide | 1 | 2021 | 731 | 0.040 |
Why?
|
Nocardia Infections | 3 | 1982 | 19 | 0.040 |
Why?
|
Staphylococcal Skin Infections | 1 | 2017 | 78 | 0.030 |
Why?
|
Health Facilities | 1 | 2022 | 575 | 0.030 |
Why?
|
Insurance Claim Reporting | 1 | 2017 | 165 | 0.030 |
Why?
|
Inappropriate Prescribing | 1 | 2019 | 212 | 0.030 |
Why?
|
Hyperglycemia | 1 | 2005 | 1375 | 0.030 |
Why?
|
Penicillins | 2 | 2015 | 403 | 0.030 |
Why?
|
Patients | 1 | 2023 | 906 | 0.030 |
Why?
|
Risk Assessment | 2 | 2015 | 24022 | 0.030 |
Why?
|
Health Plan Implementation | 1 | 2019 | 336 | 0.030 |
Why?
|
Drug Combinations | 3 | 2021 | 2048 | 0.030 |
Why?
|
Length of Stay | 2 | 2024 | 6417 | 0.030 |
Why?
|
Medical Audit | 1 | 2017 | 452 | 0.030 |
Why?
|
Treatment Outcome | 3 | 2019 | 64681 | 0.030 |
Why?
|
Exanthema | 1 | 1981 | 503 | 0.030 |
Why?
|
Clinical Coding | 1 | 2017 | 181 | 0.030 |
Why?
|
Bacterial Proteins | 1 | 2009 | 3836 | 0.030 |
Why?
|
Soft Tissue Infections | 1 | 2017 | 168 | 0.030 |
Why?
|
Health Care Costs | 1 | 2009 | 3239 | 0.030 |
Why?
|
Cefuroxime | 1 | 2015 | 23 | 0.030 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2019 | 385 | 0.030 |
Why?
|
Bacteriuria | 1 | 2015 | 102 | 0.030 |
Why?
|
Cefazolin | 1 | 2015 | 94 | 0.030 |
Why?
|
Candida | 1 | 2015 | 172 | 0.030 |
Why?
|
Child | 7 | 2023 | 80154 | 0.030 |
Why?
|
Microbial Sensitivity Tests | 3 | 2016 | 1936 | 0.030 |
Why?
|
Research Report | 1 | 2017 | 367 | 0.030 |
Why?
|
Ethics Committees, Research | 1 | 2015 | 196 | 0.030 |
Why?
|
Housekeeping, Hospital | 1 | 2013 | 17 | 0.030 |
Why?
|
Multi-Institutional Systems | 1 | 2013 | 43 | 0.030 |
Why?
|
Confidentiality | 1 | 2017 | 605 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2010 | 10218 | 0.030 |
Why?
|
Societies, Medical | 2 | 2018 | 3923 | 0.030 |
Why?
|
Guideline Adherence | 2 | 2014 | 2220 | 0.030 |
Why?
|
Risk Factors | 2 | 2018 | 74241 | 0.030 |
Why?
|
Colon | 1 | 2021 | 1791 | 0.030 |
Why?
|
Genes, Bacterial | 1 | 2016 | 1073 | 0.030 |
Why?
|
Psoas Muscles | 1 | 1992 | 66 | 0.030 |
Why?
|
Catfishes | 1 | 1992 | 14 | 0.030 |
Why?
|
Guidelines as Topic | 2 | 2011 | 1385 | 0.020 |
Why?
|
Virus Shedding | 1 | 2012 | 109 | 0.020 |
Why?
|
Selection, Genetic | 1 | 2016 | 871 | 0.020 |
Why?
|
Viral Load | 1 | 2021 | 3328 | 0.020 |
Why?
|
Vaccines, Attenuated | 1 | 2012 | 315 | 0.020 |
Why?
|
Bites and Stings | 1 | 1992 | 93 | 0.020 |
Why?
|
Random Allocation | 1 | 2015 | 2393 | 0.020 |
Why?
|
Aeromonas | 1 | 1990 | 16 | 0.020 |
Why?
|
Tuberculosis, Pulmonary | 1 | 1977 | 830 | 0.020 |
Why?
|
Time Factors | 2 | 2023 | 39957 | 0.020 |
Why?
|
Bacteria, Aerobic | 1 | 1989 | 24 | 0.020 |
Why?
|
Cost-Benefit Analysis | 2 | 2017 | 5493 | 0.020 |
Why?
|
Serratia marcescens | 1 | 1989 | 46 | 0.020 |
Why?
|
Organizational Policy | 1 | 2012 | 431 | 0.020 |
Why?
|
Oropharynx | 1 | 1989 | 137 | 0.020 |
Why?
|
Adolescent | 7 | 2019 | 88300 | 0.020 |
Why?
|
Pneumonia, Aspiration | 1 | 1989 | 145 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2019 | 2317 | 0.020 |
Why?
|
Enterobacteriaceae | 1 | 1990 | 161 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2015 | 2706 | 0.020 |
Why?
|
Inpatients | 1 | 2020 | 2545 | 0.020 |
Why?
|
Hospital Costs | 1 | 2014 | 947 | 0.020 |
Why?
|
Equipment Contamination | 1 | 1989 | 182 | 0.020 |
Why?
|
Pneumococcal Infections | 1 | 1992 | 501 | 0.020 |
Why?
|
Foreign Bodies | 1 | 1992 | 402 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2017 | 2691 | 0.020 |
Why?
|
Epidemiologic Methods | 1 | 2012 | 1336 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2016 | 6067 | 0.020 |
Why?
|
Immunotherapy | 1 | 2003 | 4642 | 0.020 |
Why?
|
Gastrointestinal Diseases | 1 | 2015 | 1201 | 0.020 |
Why?
|
Communicable Diseases, Emerging | 1 | 2008 | 148 | 0.020 |
Why?
|
Terminology as Topic | 1 | 2013 | 1528 | 0.020 |
Why?
|
Mortality | 1 | 2017 | 2896 | 0.020 |
Why?
|
Mass Chest X-Ray | 1 | 1985 | 18 | 0.020 |
Why?
|
Drug Resistance | 1 | 2012 | 1594 | 0.020 |
Why?
|
Histoplasmosis | 1 | 1986 | 63 | 0.020 |
Why?
|
Interprofessional Relations | 1 | 2012 | 990 | 0.020 |
Why?
|
Tetanus | 1 | 1985 | 51 | 0.020 |
Why?
|
Diphtheria | 1 | 1985 | 33 | 0.020 |
Why?
|
Sulfamethoxazole | 2 | 1982 | 51 | 0.020 |
Why?
|
Rubella | 1 | 1985 | 55 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2016 | 4739 | 0.020 |
Why?
|
Trimethoprim | 2 | 1982 | 78 | 0.020 |
Why?
|
Poliomyelitis | 1 | 1985 | 92 | 0.010 |
Why?
|
Tuberculin Test | 1 | 1985 | 205 | 0.010 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2015 | 1413 | 0.010 |
Why?
|
Incidence | 2 | 2017 | 21366 | 0.010 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2015 | 1394 | 0.010 |
Why?
|
Comorbidity | 1 | 2019 | 10516 | 0.010 |
Why?
|
Sentinel Surveillance | 1 | 2006 | 291 | 0.010 |
Why?
|
Decision Making | 1 | 2017 | 3931 | 0.010 |
Why?
|
Measles | 1 | 1985 | 181 | 0.010 |
Why?
|
Quality Improvement | 1 | 2018 | 3808 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2021 | 20118 | 0.010 |
Why?
|
Reference Standards | 1 | 1985 | 1005 | 0.010 |
Why?
|
Sex Factors | 1 | 2015 | 10553 | 0.010 |
Why?
|
Haemophilus Infections | 1 | 1981 | 94 | 0.010 |
Why?
|
Skin Diseases, Infectious | 1 | 1981 | 76 | 0.010 |
Why?
|
Immunization | 1 | 1985 | 1218 | 0.010 |
Why?
|
Child, Preschool | 5 | 2019 | 42225 | 0.010 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2005 | 454 | 0.010 |
Why?
|
Haemophilus influenzae | 1 | 1981 | 178 | 0.010 |
Why?
|
Hepatitis | 1 | 2003 | 228 | 0.010 |
Why?
|
Catheterization | 1 | 2006 | 1428 | 0.010 |
Why?
|
Infant | 4 | 2019 | 36170 | 0.010 |
Why?
|
Hepatitis B | 1 | 1985 | 703 | 0.010 |
Why?
|
Cardiac Surgical Procedures | 1 | 2015 | 3627 | 0.010 |
Why?
|
Amikacin | 1 | 1979 | 47 | 0.010 |
Why?
|
Kanamycin | 1 | 1979 | 63 | 0.010 |
Why?
|
Mass Screening | 1 | 2014 | 5426 | 0.010 |
Why?
|
Lung Abscess | 1 | 1978 | 40 | 0.010 |
Why?
|
Drug Eruptions | 1 | 1981 | 335 | 0.010 |
Why?
|
Nocardia | 1 | 1977 | 9 | 0.010 |
Why?
|
DNA, Bacterial | 1 | 2002 | 1470 | 0.010 |
Why?
|
Acute Disease | 2 | 1979 | 7226 | 0.010 |
Why?
|
Herpes Simplex | 1 | 1981 | 465 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39127 | 0.010 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1986 | 2196 | 0.010 |
Why?
|
Encephalitis | 1 | 1981 | 438 | 0.010 |
Why?
|
Streptococcus pyogenes | 1 | 1979 | 292 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2010 | 3885 | 0.010 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2003 | 782 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 1979 | 1989 | 0.010 |
Why?
|
Syndrome | 1 | 1981 | 3271 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2015 | 26072 | 0.010 |
Why?
|
Blood Glucose | 2 | 2005 | 6392 | 0.010 |
Why?
|
Drainage | 1 | 1978 | 1157 | 0.010 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2003 | 2223 | 0.010 |
Why?
|
Wounds, Penetrating | 1 | 1992 | 314 | 0.010 |
Why?
|
Sulfonamides | 1 | 1979 | 1977 | 0.010 |
Why?
|
Fingers | 1 | 1992 | 506 | 0.000 |
Why?
|
Bone and Bones | 1 | 1979 | 2568 | 0.000 |
Why?
|
Muscular Diseases | 1 | 1992 | 552 | 0.000 |
Why?
|
Chronic Disease | 2 | 1979 | 9319 | 0.000 |
Why?
|
Postoperative Complications | 1 | 1989 | 15637 | 0.000 |
Why?
|
Fractures, Bone | 1 | 1979 | 2046 | 0.000 |
Why?
|
Knee Joint | 1 | 1992 | 1678 | 0.000 |
Why?
|
Opportunistic Infections | 1 | 1986 | 376 | 0.000 |
Why?
|
Counterimmunoelectrophoresis | 1 | 1981 | 14 | 0.000 |
Why?
|
Agglutination Tests | 1 | 1981 | 41 | 0.000 |
Why?
|
Facial Dermatoses | 1 | 1981 | 86 | 0.000 |
Why?
|
Serotyping | 1 | 1981 | 325 | 0.000 |
Why?
|
Nocardia asteroides | 1 | 1979 | 9 | 0.000 |
Why?
|
Vidarabine | 1 | 1981 | 336 | 0.000 |
Why?
|
Pseudomonas fluorescens | 1 | 1978 | 22 | 0.000 |
Why?
|
Acidosis | 1 | 1980 | 269 | 0.000 |
Why?
|
Drug Synergism | 1 | 1982 | 1756 | 0.000 |
Why?
|
Tomography, Emission-Computed | 1 | 1981 | 1123 | 0.000 |
Why?
|
Neck | 1 | 1981 | 734 | 0.000 |
Why?
|
Blood Coagulation Disorders | 1 | 1980 | 350 | 0.000 |
Why?
|
Streptococcus pneumoniae | 1 | 1980 | 730 | 0.000 |
Why?
|
Mice, Inbred BALB C | 1 | 1979 | 6200 | 0.000 |
Why?
|
Lymph Nodes | 1 | 1981 | 3461 | 0.000 |
Why?
|
Escherichia coli | 1 | 1980 | 4201 | 0.000 |
Why?
|
Risk | 1 | 1978 | 9616 | 0.000 |
Why?
|
Animals | 2 | 1992 | 168089 | 0.000 |
Why?
|
Lung | 1 | 1978 | 9979 | 0.000 |
Why?
|
Mice | 1 | 1979 | 81330 | 0.000 |
Why?
|